Cures Acceleration Network Review Board
Authorized to reduce significant barriers to successful translation and accelerate the development of high-need cures, the Cures Acceleration Network (CAN) provides NCATS with flexibility in how it funds projects. Implementation of this authority is guided by the CAN Review Board, which according to its charter, advises and provides recommendations to the NCATS director on the policies, programs and procedures for carrying out the duties of the Office of the Director and on identifying significant barriers to successful translation of basic science into clinical application.
The Board is comprised of members who are appointed by the Secretary of the U.S. Department of Health and Human Services. Members serve four-year terms. Ex-officio members from NIH, the Office of the Assistant Secretary of Defense for Health Affairs, the Office of the Under Secretary for Health for the Department of Veterans Affairs, the National Science Foundation, and the U.S. Food and Drug Administration also are appointed and serve three-year terms.
The CAN Review Board meets four times each year. View the schedule below for upcoming meetings; past meeting minutes, agendas and videocasts also are available.
8:30 a.m. to 5:00 p.m.
National Institutes of Health
Building 31C, 6th Floor, Conference Room 10
Bethesda, Md. 20892
This joint meeting of the National Center for Advancing Translational Sciences Advisory Council and the Cures Acceleration Network (CAN) Review Board will feature presentations by NCATS leadership, the CAN Review Board and invited guests. The meeting will feature a Director’s Report, a presentation by the NCATS Advisory Council Working Group on the IOM CTSA Program Report, and proposed CAN initiatives for Fiscal Year 2015. Council subcommittees also will report on 1) patient engagement; 2) partnerships with pharmaceutical and biotechnology companies, and venture capital firms; and 3) medical technologies. In addition, NCATS staff will present a Concept Clearance of proposed initiatives for consideration and approval by Council.
IOM Workshop on CAN
As requested by Congress, NCATS contracted with the Institute of Medicine (IOM) to host a two-day workshop to discuss the authorities provided to NCATS by the recently authorized Cures Acceleration Network (CAN). “Maximizing the Goals of the Cures Acceleration Network to Accelerate the Development of New Drugs and Diagnostics: A Workshop” was held on June 4-5, 2012.
On Sept. 16, 2013, NCATS Director Christopher P. Austin, M.D., led a joint meeting of the NCATS Advisory Council and Cures Acceleration Network Review Board.